麻豆视频

South America Ultrasound Devices Market Trends and Insights

Expansion of Imaging Reimbursement Boosting Ultrasound Adoption

Broader reimbursement schemes are strengthening the South America ultrasound devices market by lowering out-of-pocket costs for patients and supporting provider economics. Brazil鈥檚 Medicare now reimburses an average USD 17,500 for histotripsy therapy, encouraging hospitals to procure high-end HIFU systems. Argentina added carotid and femoral ultrasound to preventive screening, revealing carotid plaques in 51% of asymptomatic adults, which underscores early detection value. Colombia extended telemedicine reimbursement to remote ultrasound interpretation, with 86% of facilities using ICTs for maternal care, fueling demand for cloud-connected probes.^{[1]Eduardo Capasso et al., 鈥淚CT Use in Maternal Care Facilities,鈥� who.int} These policy shifts reinforce supplier incentives to align product portfolios with reimbursed procedures. Healthy reimbursement further alleviates margin pressure for providers operating in cash-limited public systems.

Escalating Non-Communicable Disease Burden Driving Demand for Cardiac & Abdominal Ultrasound

Non-communicable diseases remain the largest mortality contributor in the region and elevate routine imaging needs. Colombia recorded 117,620 new cancer cases in 2024, accelerating uptake of real-time ultrasound for tumor staging and guidance. Vascular ultrasound studies in Argentina detected subclinical carotid plaques in more than half of tested adults, signifying a silent surge in atherosclerosis. Brazil鈥檚 elderly population is set to reach 37.8% by 2070, and life expectancy could climb to 83.9 years, broadening chronic disease management workloads. Continuous imaging underpins timely intervention, particularly for cardiac, abdominal, and vascular assessments. Consequently, hospitals are enlarging their ultrasound fleets while outpatient centers focus on portable devices for routine follow-up.

Adoption of AI-Enabled & Wireless Ultrasound Solutions Enhancing Workflow Efficiency

AI algorithms now automate fetal measurements and improve organ segmentation, reducing scan times by up to 40% on devices such as GE HealthCare鈥檚 Voluson Signature.^{[2]鈥淰oluson Signature Launch,鈥� gehealthcare.com} Workflow acceleration helps mitigate shortages of certified sonographers, a major obstacle outside capital cities. Wireless probes integrate seamlessly with smartphones, fostering point-of-care use in ambulances and community clinics. AI-assisted interpretation expands the South America ultrasound devices market by enabling less-skilled personnel to conduct basic exams, while cloud connectivity supports specialist review. Rising connectivity in Chile and Colombia bolsters remote collaboration, accelerating decision-making and optimising resource allocation.

Government and Private Funding for R&D in Ultrasound Imaging

Policy makers recognise ultrasound鈥檚 cost advantage over CT or MRI and are channeling funds into next-generation systems. Argentina secured a USD 200 million Inter-American Development Bank loan in 2023 to enlarge diagnostic imaging coverage, directly benefiting public hospitals.^{[3]鈥淚nter-American Development Bank Loan for Argentina Imaging,鈥� iadb.org} Venture investors committed USD 102 million to histotripsy developer HistoSonics, highlighting strong appetite for therapeutic ultrasound platforms. These inflows encourage collaboration between academia and suppliers, focusing on improved transducer materials, battery life, and AI firmware. Over the medium term, faster innovation cycles will broaden clinical indications and maintain pricing flexibility, reinforcing the South America ultrasound devices market growth trajectory.

Prolonged & Divergent Regulatory Approval Processes

Medical device firms face heterogeneous and often lengthy approval frameworks that slow product launches. Brazil鈥檚 ANVISA requires Class III and Class IV systems to obtain full registration and Brazil-Good Manufacturing Practice certificates, extending timelines by 5-6 months. Although 2024 regulations permit reliance on foreign approvals, discordant documentation rules across neighboring countries still impose added compliance cost. The constraint curbs initial market entrance for smaller innovators and prolongs access to the latest features, dampening the competitive intensity within the South America ultrasound devices market.

Limited Availability of Certified Sonographers and Radiologists in Secondary Cities

Specialist shortages limit service expansion beyond metropolitan hubs. The PROVAR+ echocardiography program in Brazil demonstrated that simplified protocols executed by nurses uncovered major heart disease in 29.2% of patients, signalling the hidden burden due to limited screening capacity. Rural hospitals often operate a single ultrasound unit staffed by rotating technicians, leading to long wait lists. This bottleneck can delay diagnoses, prompt patients to travel to urban centers, and constrain equipment utilisation rates, collectively tempering growth momentum in the South America ultrasound devices market.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Application: Diagnostic Dominance Amid Accelerating Anesthesiology Growth

Radiology upheld supremacy in the South America ultrasound devices market with 26.46% share in 2025, backed by its integral role in multi-specialty diagnostics and the growing integration of AI-powered measurement tools. The South America ultrasound devices market size for radiology benefited from faster workflow, as seen with Siemens Acuson Sequoia 3.5 that automates organ labeling. Cardiology and gynecology/obstetrics remain sizable due to heightened screening, while critical care leverages point-of-care scanning for rapid triage.

Anesthesiology is projected to log a 4.82% CAGR through 2031, marking the quickest rise among applications. Wider uptake of ultrasound-guided nerve blocks improves procedural success and patient outcomes; Mindray鈥檚 regional anesthesia education series strengthens clinician proficiency. Hospital procurement teams now bundle portable probes with operating-room carts, sustaining momentum. Rising surgical volumes and enhanced patient safety protocols will continue to propel anesthesiology鈥檚 contribution to the South America ultrasound devices market.

By Technology: 3D/4D Lead as Therapeutic HIFU Accelerates

The 3D/4D technology tier captured 46.88% of the South America ultrasound devices market share in 2025, driven by superior volumetric clarity essential for fetal assessments and oncology staging. AI-enabled platforms like GE Voluson Signature 20 shorten second-trimester exams by 40%, underscoring efficiency gains. Conventional 2D remains relevant through AI-enhanced image optimisation, while Doppler supports cardiovascular evaluation.

HIFU systems will record a 5.02% CAGR to 2031, the fastest among technologies, buoyed by non-invasive tumor ablation success. Liver cancer histotripsy cases surpassing 300 globally demonstrate clinical acceptance. Expansion into prostate and uterine fibroid therapy will widen indications, adding momentum to the South America ultrasound devices market size growth for therapeutic platforms.

By Portability: Stationary Systems Retain Scale as Handheld Units Surge

Stationary consoles delivered 70.92% revenue in 2025 owing to comprehensive transducer arrays and full imaging suites required by tertiary hospitals. Acoustic Intelligence embedded in Mindray Resona A20 enhances diagnostic certainty, sustaining demand. Service agreements and upgrade pathways further entrench installed bases among large institutions.

Handheld/pocket models will progress at a 7.05% CAGR, more than double the overall market rate. Butterfly iQ3's lighter design and 3D capabilities resonate with emergency and primary-care clinicians. Cloud-based quality assurance aids training, compressing the skills gap. As procurement policies shift toward mobility, portable cart systems bridge functionality and transportability, reinforcing incremental adoption across the South America ultrasound devices market.

By End User: Hospital Leadership with Outpatient Momentum

Hospitals accounted for 57.62% of 2025 sales and continue to serve as reference sites for new product launches, including GE Versana Premier equipped with AI tools for multi-specialty workflows. Intensifying surgery throughput and the need for intraoperative guidance uphold console purchases.

Ambulatory care centres should clock a 6.41% CAGR to 2031 as cost-conscious payers steer procedures to outpatient settings. Compact and battery-operated units allow fast turnover and lower capital expenditure. Diagnostic imaging centres maintain volume for specialised exams, while physician offices and home-care programs gradually adopt mobile probes, extending market reach.

Geography Analysis

Brazil controlled 48.35% of the South America ultrasound devices market in 2025 underpinned by the continent鈥檚 largest healthcare budget and ongoing reimbursement expansion. ANVISA鈥檚 2024 acceptance of foreign regulatory certificates trims approval timelines and encourages first-to-market launches. Tele-cardiology pilots like PROVAR+ illustrate remote reading feasibility, increasing utilisation across public clinics.

Argentina is forecast to achieve a 3.99% CAGR, benefiting from a USD 600 million credit line aimed at imaging upgrades. Prevalence of subclinical atherosclerosis revealed via vascular ultrasound highlights unmet need and supports volume growth. Chile and Colombia advance on the back of digital health readiness, with Colombia鈥檚 86% ICT adoption in maternal care underpinning tele-ultrasound uptake.

Rest of South America, including Peru and Uruguay, exhibits sizeable whitespace for portable devices that bypass infrastructure constraints, while regulatory simplification could expedite entry in smaller markets. Steady urban migration and rising chronic disease prevalence ensure sustained demand, expanding the South America ultrasound devices market footprint across diverse economic contexts.

Regulatory Landscape

Regulatory oversight for ultrasound devices in South America is country-specific, with Brazil, Argentina, and Colombia setting the pace on registration, post-market controls, and traceability. In Brazil, ANVISA applies quality and safety requirements for medical ultrasound equipment under Instrucao Normativa (IN) No 96 (2021), including acceptance and quality control testing practices that affect hospital commissioning and service schedules. ANVISA is also advancing Unique Device Identification (UDI) labeling under RDC No 591 (2021), with UDI labeling requirements already in force for Class IV devices since July 2025 and for Class III devices since January 2026.

Digital traceability infrastructure is becoming a practical compliance gate for manufacturers and importers. ANVISA published IN No 426 (2026) establishing the SIUD database for UDI data submission, effective March 1, 2026, increasing the need for aligned labeling, packaging, and data governance for ultrasound system components placed on the Brazilian market. In Argentina, ANMAT issued Disposicion 236/2026 (February 2026) covering risk Class I and II medical products (and certain IVD products) of foreign origin, while establishment habilitation processes are increasingly handled through digital systems such as THEMIS (per Disposicion 8799/2025). In Colombia, INVIMA is implementing UDI and semantic coding requirements under Resolucion 1405 of 2022, including mandatory UDI-DI reporting deadlines (for example, a February 9, 2026 requirement for certain Class IIa devices registered before February 2024), reinforcing cross-country emphasis on device identification and lifecycle surveillance.

Market Opportunities and Future Outlook

White-space in South America remains in secondary cities and underserved corridors where point-of-care ultrasound can bypass infrastructure constraints and specialist shortages. Butterfly Network expanded availability of its iQ+ and iQ3 handheld ultrasound devices and mobile application in Brazil via authorized distribution partners in 2026, broadening access to frontline settings and increasing competitive intensity in the handheld/wireless segment where subscription and app-based workflows are part of the offering. Similar whitespace exists for cloud-connected probes and workflow tools that support remote oversight, aligning with telemedicine-integrated ultrasound adoption in countries such as Colombia.

Institutional modernization programs and procurement centralization create another opportunity axis, particularly in Brazil where the Ministry of Health launched a National Investment Plan for the SUS Medical Device Park for 2026-2031, coordinated through the CT-Equipo technical chamber to guide technology upgrades and access to diagnostics. Suppliers that align product configurations, service models, and interoperability to public-sector workflows can compete for replacement and fleet expansion cycles in hospitals and outpatient networks. At the same time, tightening traceability requirements are shaping go-to-market priorities: ANVISA has been rolling out UDI obligations and the SIUD database (effective March 2026), making data readiness, labeling compliance, and local regulatory operations a differentiator for sustained participation across Brazil and, by extension, for multi-country launches where UDI and digital reporting are increasingly mirrored by regulators such as ANMAT and INVIMA.